Capillary Dynamics Regulate Post-Ischemic Muscle Damage and Regeneration in Experimental Hindlimb Ischemia

Cells. 2023 Aug 14;12(16):2060. doi: 10.3390/cells12162060.

Abstract

This study aimed to show the significance of capillary function in post-ischemic recovery from the perspective of physiological parameters, such as blood flow, hemoglobin oxygenation and tissue regeneration. Muscle-level microvascular alterations of blood flow and hemoglobin oxygenation, and post-ischemic myofiber and capillary responses were analyzed in aged, healthy C57Bl/6J mice (n = 48) and aged, hyperlipidemic LDLR-/-ApoB100/100 mice (n = 69) after the induction of acute hindlimb ischemia using contrast ultrasound, photoacoustic imaging and histological analyses, respectively. The capillary responses that led to successful post-ischemic muscle repair in C57Bl/6J mice included an early capillary dilation phase, preceding the return of arterial driving pressure, followed by an increase in capillary density that further supported satellite cell-induced muscle regeneration. Initial capillary enlargement was absent in the LDLR-/-ApoB100/100 mice with lifelong moderate hypercholesterolemia and led to an inability to recover arterial driving pressure, with a resulting increase in distal necrosis, chronic tissue damage and a delay in the overall recovery after ischemia. To conclude, this manuscript highlights, beyond arterial collateralization, the importance of the proper function of the capillary endothelium in post-ischemic recovery and displays how post-ischemic capillary dynamics associate beyond tissue blood flow to both hemoglobin oxygenation and tissue regeneration.

Keywords: blood flow; capillary remodeling; hyperlipidemia; hypoxia; ischemia; muscle damage; regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arteries*
  • Endothelium, Vascular
  • Hindlimb
  • Ischemia*
  • Mice
  • Mice, Inbred C57BL
  • Muscles

Grants and funding

This research was funded by the Finish Academy (Clinical Researcher 324070 and Research Project 339560, Flagship program GeneCellNano (grant number 337120) and Centre of Excellence in Cardiovascular and Metabolic Disease), the European Research Council (ERC) Advanced Grant (grant number 884382), Biocentre Finland, the Kuopio University Foundation, the Heart Research Foundation and the Maire Taponen Foundation.